1. McNarama MT, Tscholakoff D, Revel D, et al. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. Radiology. 1986. 158:765–769.
2. Saeed M, Wendland MF, Takehara Y, Higgins CB. Reversible and irreversible injury in the reperfused myocardium: differentiation with contrast material-enhanced MR imaging. Radiology. 1990. 175:633–637.
3. Pereira RS, Prato FS, Wisenberg G, Sykes J. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med. 1996. 36:684–693.
4. Gray WR Jr, Parkey RW, Buja LM, et al. Computed tomography: in vitro evaluation of myocardial infarction. Radiology. 1977. 122:511–513.
5. Hessel SJ, Adams DF, Judy PF, Fishbein MC, Abrams HL. Detection of myocardial ischemia in vitro by computed tomography. Radiology. 1978. 127:413–418.
6. Higgins CB, Siemers PT, Schmidt W, et al. Evaluation of myocardial ischemic damage of various ages by computerized transmission tomography. Time-dependent effects of contrast material. Circulation. 1979. 60:284–291.
7. Cipriano PR, Nassi M, Ricci MT, Reitz BA, Brody WR. Acute myocardial ischemia detected in vivo by computed tomography. Radiology. 1981. 140:727–731.
8. Mochizuki T, Murase K, Higashino H, Koyama Y, Azemoto S, Ikezoe J. Demonstration of acute myocardial infarction by subsecond spiral computed tomography: early defect and delayed enhancement. Circulation. 1999. 99:2058–2059.
9. Hilfiker PR, Weishaupt D, Marincek B. Multislice spiral computed tomography of subacute myocardial infarction. Circulation. 2001. 104:1083.
10. Fishbein MC, Meerbaum S, Rit J, et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J. 1981. 101:593–600.
11. Sicari R, Picano E, Landi P, et al. Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative (EDIC) Study. J Am Coll Cardiol. 1997. 29:254–260.
12. Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol. 1996. 27:132–139.
13. Phelps ME, Hoffman EJ, Selin C, et al. Investigation of [18F]2-deoxyglucose for the measure of myocardial glucose metabolism. J Nucl Med. 1978. 19:1311–1319.
14. Burt RW, Perkins OW, Oppenheim BE, et al. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability. J Nucl Med. 1995. 36:176–179.
15. Kuijper AF, Vliegen HW, van der Wall EE, et al. The clinical impact of thallium-201 reinjection scintigraphy for detection of myocardial viability. Eur J Nucl Med. 1992. 19:783–789.
16. Wesbey G, Higgins CB, Lanzer P, Botvinick E, Lipton MJ. Imaging and characterization of acute myocardial infarction in vivo by gated nuclear magnetic resonance. Circulation. 1984. 69:125–130.
17. Ratner RV, Okada RD, Newell JB, Pohost GM. The relationship between proton nuclear magnetic resonance relaxation parameters and myocardial perfusion with acute coronary arterial occlusion and reperfusion. Circulation. 1985. 71:823–828.
18. Tscholakoff D, Higgins CB, McNamara MT, Derugin N. Early-phase myocardial infarction: evaluation by MR imaging. Radiology. 1986. 159:667–672.
19. McNamara MT, Tscholakoff D, Revel D, et al. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. Radiology. 1986. 158:765–769.
20. Peshock RM, Malloy CR, Buja LM, Nunnally RL, Parkey RW, Willerson JT. Magnetic resonance imaging of acute myocardial infarction: gadolinium diethylenetriamine pentaacetic acid as a marker of reperfusion. Circulation. 1986. 74:1434–1440.
21. McNamara MT, Higgins CB, Ehman RL, Revel D, Sievers R, Brasch RC. Acute myocardial ischemia: magnetic resonance contrast enhancement with gadolinium-DTPA. Radiology. 1984. 153:157–163.
22. Tscholakoff D, Higgins CB, Sechtem U, McNamara MT. Occlusive and reperfused myocardial infarcts: effects of Gd-DTPA on ECG-gated MR imaging. Radiology. 1986. 160:515–519.
23. Wesbey GE, Higgins CB, McNarama MT, et al. Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. Radiology. 1984. 153:165–169.
24. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999. 100:1992–2002.
25. Choi SI, Jiang CZ, Lim KH, et al. Application of breath-hold T2-weighted, first-pass perfusion and gadolinium-enhanced T1-weighted MR imaging for assessment of myocardial viability in a pig model. J Magn Reson Imaging. 2000. 11:476–480.
26. Saeed M, Bremerich J, Wendland MF, Wyttenbach R, Weinmann HJ, Higgins CB. Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. Radiology. 1999. 213:247–257.
27. Arheden H, Saeed M, Higgins CB, et al. Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging. Radiology. 2000. 215:520–528.
28. Schaefer S, Malloy CR, Katz J, et al. Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. J Am Coll Cardiol. 1988. 12:1064–1072.
29. Saeed M, Lund G, Wendland MF, Bremerich J, Weinmann H, Higgins CB. Magnetic resonance characterization of the periinfarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation. 2001. 103:871–876.
30. Rogers WJ Jr, Kramer CM, Geskin G, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation. 1999. 99:744–750.
31. Willmann JK, Szente-Varga M, Roos JE, Hilfiker PR, Weishaupt D. Three-dimensional images of extra-anatomic arterial bypass graft using multidetector row spiral computed tomography data with volume rendering. Circulation. 2001. 104:E154–E155.
32. Budoff MJ, Achenbach S, Duerinckx A. Clinical utility of computed tomography and magnetic resonance techniques for noninvasive coronary angiography. J Am Coll Cardiol. 2003. 42:1867–1878.